News Headlines Article

5 questions after Amgen’s $10.4 billion Onyx buyout
San Francisco Business Times

Amgen Inc.’s $10.4 billion cash buyout of Onyx Pharmaceuticals Inc. leaves a bunch of unanswered questions. The answers may come soon, however, as leaders of Amgen (NASDAQ: AMGN), the world’s largest biotech company, and South San Francisco-based Onyx (NASDAQ: ONXX) climb on a Monday morning conference call.